Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
36 participants
OBSERVATIONAL
2019-10-07
2020-05-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It must be noted that there is an increase of complementary therapies including Touch-Massage. Studies showed its interest on quality of life, anxiety, pain and fatigue.
The concept Touch-massage (TM) is defined as a benevolent concern that takes shape through the touch and the sequence of gesture on all or parts of the body. This allows to calm, to relax, to get back into shape, to reassure, to communicate or simply to provide well-being, enjoyable to receive and to practice.
This treatment is already offered to the patients at the ICO, in priority while the first course of chemotherapy, but in an informal way. I has been noticed a better-being after the TM, and an increase of demand from the patients. This is why it would be interested to measure the evolution of quality of life of those patients having a chemotherapy for a breast cancer getting or not a TM.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring the Effects of Touch Relaxation Painful Patients in Oncologie Nursing
NCT02857114
Effects of an Integrative Day-care Clinic Program for Breast Cancer Patients During Chemotherapy
NCT03868865
Development of Personalized Health Care Service in Patients With Breast Cancer
NCT03194399
The Effect of Appropriate Family Companionship on the Physical and Mental Health of Patients With Advanced Breast Cancer
NCT06385665
Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer
NCT00533780
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The filling of the questionnaires will occur at the 4 first courses (C1 to C4). The Touch Massage will be offered for the 3 first courses of chemotherapy (C1 to C3). The patient can refuse the TM but she will have to fill the questionnaires.
At each moment, the patient can withdraw from the study, the TM can be offered according to the availability of the team and of the choice of the patient during the course of chemotherapy.
The questionnaire collection will be done in the patient's room. The quality of life will be evaluated based on the questionnaires EORTC, QLQ C30 and BR23 at C1 and C2. The evaluation of the quality of life at the fourth course will allow to estimate the quality of life after 3 complete courses of chemotherapy. Alongside, the anxiety will be evaluated with the anxiety scale STAI from C1 to C3, when the patient just arrives in the service and before she leaves. At the fourth course, the questionnaire will be filled only at the arrival.
After the filling of the questionnaires, the patient will be seen by the medical doctor of the service and the nurse who will take charge of her for the chemotherapy.
According the availability of the service, the patient will receive the TM if she wants. A member of the nursing staff formed to the TM (formation dispensed to the ICO) will perform the TM. It will be done during the chemotherapy, during the perfusion of ENDOXAN, which takes an hour. The TM will last 20 minutes. In this way, the TM will not delayed, prolonged and disturb the treatment. At C4, there will not be a TM.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
women with adjuvant breast cancer
Women between 18 and 70 years old with an adjuvant breast cancer histologically characterized
Women between 18 and 70 years old with an adjuvant breast cancer histologically characterized
Quality of life and anxiety questionnaires before the course of chemotherapy (C1 and C4).
Touch-Massage during the course of chemotherapy (from C1 to C3) Anxiety questionnaire at the end of the course of chemotherapy (from C1 to C3)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Women between 18 and 70 years old with an adjuvant breast cancer histologically characterized
Quality of life and anxiety questionnaires before the course of chemotherapy (C1 and C4).
Touch-Massage during the course of chemotherapy (from C1 to C3) Anxiety questionnaire at the end of the course of chemotherapy (from C1 to C3)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with histologically confirmed breast cancer
* adjuvant situation
* spoken language : french
* patient who never had chemotherapy in the past
Exclusion Criteria
* Malformation of the back
* Wound at the level of the zones to massage
* Patient placed under the authority of a tutor
* Pregnant patient
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Cancerologie de l'Ouest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sandra PIQUIN, Nurse
Role: STUDY_DIRECTOR
Insitut de Cancérologie de l'Ouest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Insitut de Cancérologie de l'Ouest
Angers, , France
Insitut de Cancérologie de l'Ouest
Angers, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICO-2019-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.